B. Michelsen Et Al. , "Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration," RMD open , vol.6, no.3, 2020
Michelsen, B. Et Al. 2020. Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration. RMD open , vol.6, no.3 .
Michelsen, B., Lindström, U., Codreanu, C., Ciurea, A., Zavada, J., Loft, A. G., ... Pombo-Suarez, M.(2020). Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration. RMD open , vol.6, no.3.
Michelsen, Brigitte Et Al. "Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration," RMD open , vol.6, no.3, 2020
Michelsen, Brigitte Et Al. "Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration." RMD open , vol.6, no.3, 2020
Michelsen, B. Et Al. (2020) . "Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration." RMD open , vol.6, no.3.
@article{article, author={Brigitte Michelsen Et Al. }, title={Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration}, journal={RMD open}, year=2020}